Cargando…
External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy
PURPOSE: Risk calculators (RC) aim to improve prebiopsy risk stratification. Their latest versions now include multiparametric magnetic resonance imaging (mpMRI) findings. For their implementation into clinical practice, critical external validations are needed. METHODS: We retrospectively analyzed...
Autores principales: | Pallauf, Maximilian, Steinkohl, Fabian, Zimmermann, Georg, Horetzky, Maximilian, Rajwa, Pawel, Pradere, Benjamin, Lindner, Andrea Katharina, Pichler, Renate, Kunit, Thomas, Shariat, Shahrokh F., Lusuardi, Lukas, Drerup, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512729/ https://www.ncbi.nlm.nih.gov/pubmed/35941246 http://dx.doi.org/10.1007/s00345-022-04119-8 |
Ejemplares similares
-
Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
por: Wei, G., et al.
Publicado: (2021) -
LithoVue™ for renal stone therapy – a perfect fit for high volume academic centers; a retrospective evaluation of 108 cases
por: Pallauf, Maximilian, et al.
Publicado: (2020) -
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022) -
Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017) -
Role of mpMRI of the prostate in screening for prostate cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2017)